Arkadios Wealth Advisors

SEC CIK: 0001800798
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

GSK holding history

GSK plc in every 13F filed by Arkadios Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overview All 13F holders of GSK Full Q2 2026 holdings

Shares (Q2 2026): 108,025
Value: $5.66M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of GSK by Arkadios Wealth Advisors, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	108,025	$5.66M	0.1%	−10.0%	Reduced	Holders
Q1 2026	108,026	$5.96M	0.1%	+647+0.6%	Added	Holders
Q4 2025	107,379	$5.27M	0.1%	+39,863+59.0%	Added	Holders
Q3 2025	67,516	$2.91M	0.1%	−1,244−1.8%	Reduced	Holders
Q2 2025	68,760	$2.64M	0.1%	+6,734+10.9%	Added	Holders
Q1 2025	62,026	$2.40M	0.1%	+7,468+13.7%	Added	Holders
Q4 2024	54,558	$1.85M	0.1%	−105−0.2%	Reduced	Holders
Q3 2024	54,663	$2.23M	0.1%	−406−0.7%	Reduced	Holders
Q2 2024	55,069	$2.12M	0.1%	−2,938−5.1%	Reduced	Holders
Q1 2024	58,007	$2.49M	0.2%	−147−0.3%	Reduced	Holders
Q4 2023	58,154	$2.16M	0.2%	−301−0.5%	Reduced	Holders
Q3 2023	58,455	$2.12M	0.2%	−712−1.2%	Reduced	Holders
Q2 2023	59,167	$2.11M	0.2%	−567−0.9%	Reduced	Holders
Q1 2023	59,734	$2.13M	0.3%	−3,902−6.1%	Reduced	Holders
Q4 2022	63,636	$1.55M	0.2%	+308+0.5%	Added	Holders
Q3 2022	63,328	$1.29M	0.2%	−9,602−13.2%	Reduced	Holders
Q2 2022	72,930	$3.17M	0.5%	−100.0%	Reduced	Holders
Q1 2022	72,940	$3.18M	0.4%	+16,933+30.2%	Added	Holders
Q4 2021	56,007	$2.47M	0.3%	−889−1.6%	Reduced	Holders
Q3 2021	56,896	$2.17M	0.3%	+2,029+3.7%	Added	Holders
Q2 2021	54,867	$2.18M	0.3%	+51,612+1,585.6%	Added	Holders
Q1 2021	3,255	$116.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.